Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-25

Clinical Trial Update: External Hypofractionated Radiotherapy With Simultaneous Integrated Boost in Early Breast Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating external hypofractionated radiotherapy with a simultaneous integrated boost for early breast cancer; the study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Regina Elena Cancer Institute | Conditions: Breast Neoplasms, Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING